{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:37:20Z","timestamp":1791232640646,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_U120097115"],"award-info":[{"award-number":["MC_U120097115"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W005557\/1"],"award-info":[{"award-number":["MR\/W005557\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V013734\/1"],"award-info":[{"award-number":["MR\/V013734\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094849\/Z\/10\/Z"],"award-info":[{"award-number":["094849\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\u2019s College London"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Converging lines of evidence implicate synaptic loss in cognitive impairment associated with schizophrenia. However, it remains unknown whether synaptic terminal density and premorbid intellectual functioning are related in vivo, or whether there are age-related changes in them in schizophrenia. To address this, we investigated whole brain grey matter synaptic vesicle glycoprotein 2A (SV2A) levels and examined their relationship with intellectual functioning and age, in forty-three patients with schizophrenia (SCZ) and 26 healthy volunteers (HV), using [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J positron emission tomography (PET). Whole brain grey matter [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J distribution volume ratio (DVR) was significantly lower in the SCZ than the HV group (Cohen\u2019s\n                    <jats:italic>d<\/jats:italic>\n                    \u2009=\u20090.64,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01), and negatively correlated with age in both groups (Spearman\u2019s rho\u2009=\u2009\u20130.46 to \u20130.55), with no significant group difference in magnitude of DVR-age correlations (\n                    <jats:italic>z<\/jats:italic>\n                    \u2009=\u20090.44,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.66). Current (Cohen\u2019s\n                    <jats:italic>d<\/jats:italic>\n                    \u2009=\u20090.73) and premorbid IQ (Cliff\u2019s delta = 0.37) were significantly lower in the SCZ than the HV group, though DVR was not significantly associated with current or premorbid IQ in either group (including in chronic medicated and early-course unmedicated SCZ subgroups). The group differences in DVR are consistent with a global deficit in synaptic terminal density in schizophrenia, with similar age-related changes in people with schizophrenia and healthy volunteers. The lack of significant relationships between DVR and premorbid or current cognitive measures are not consistent with the hypothesis that lower levels of synaptic terminal density observed in schizophrenia underlie lower levels of intellectual functioning in the disorder.\n                  <\/jats:p>","DOI":"10.1038\/s41386-026-02349-7","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:26:37Z","timestamp":1770085597000},"page":"1023-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [11C]UCB-J positron emission tomography study"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8108-1225","authenticated-orcid":false,"given":"Ellis Chika","family":"Onwordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Whitehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Shatalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atheeshaan","family":"Arumuham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-8464","authenticated-orcid":false,"given":"Martin","family":"Osugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-7661","authenticated-orcid":false,"given":"Tiago Reis","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Jauhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-6687","authenticated-orcid":false,"given":"Eugenii A.","family":"Rabiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger N.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7499-1714","authenticated-orcid":false,"given":"Sridhar","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Reichenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-1972","authenticated-orcid":false,"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.","journal-title":"PLoS Med"},{"key":"2349_CR2","doi-asserted-by":"crossref","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020;77:201\u2013210.","DOI":"10.1001\/jamapsychiatry.2019.3360"},{"key":"2349_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473\u201386.","journal-title":"Lancet"},{"key":"2349_CR4","doi-asserted-by":"crossref","unstructured":"Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.","DOI":"10.1016\/j.neuropharm.2019.107704"},{"key":"2349_CR5","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318.","journal-title":"Mol Psychiatry"},{"key":"2349_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s40265-017-0789-y","volume":"77","author":"SRT Veerman","year":"2017","unstructured":"Veerman SRT, Schulte PFJ, de Haan L. Treatment for negative symptoms in schizophrenia: a comprehensive review. Drugs. 2017;77:1423\u201359.","journal-title":"Drugs"},{"key":"2349_CR7","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1017\/S0033291723001770","volume":"53","author":"A Stainton","year":"2023","unstructured":"Stainton A, Chisholm K, Griffiths SL, Kambeitz-Ilankovic L, Wenzel J, Bonivento C, et al. Prevalence of cognitive impairments and strengths in the early course of psychosis and depression. Psychol Med. 2023;53:5945\u201357.","journal-title":"Psychol Med"},{"key":"2349_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2021.100234","volume":"28","author":"EK Mwesiga","year":"2022","unstructured":"Mwesiga EK, Robbins R, Akena D, Koen N, Nakku J, Nakasujja N, et al. Prevalence, profile and associations of cognitive impairment in Ugandan first-episode psychosis patients. Schizophr Res Cogn. 2022;28:100234.","journal-title":"Schizophr Res Cogn"},{"key":"2349_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06315-9","volume":"24","author":"OK Ugwuonye","year":"2024","unstructured":"Ugwuonye OK, Onu JU, Iyidobi TO, Ohaeri JU. Prevalence of neurocognitive deficits in patients with first-episode schizophrenia in an African sample and its relationship with dimensions of psychopathology and psychosocial outcome. BMC Psychiatry. 2024;24:866.","journal-title":"BMC Psychiatry"},{"key":"2349_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.638773","volume":"12","author":"XJ Peng","year":"2021","unstructured":"Peng XJ, Hei GR, Yang Y, Liu CC, Xiao JM, Long YJ, et al. The association between cognitive deficits and clinical characteristic in first-episode drug naive patients with schizophrenia. Front Psychiatry. 2021;12:638773.","journal-title":"Front Psychiatry"},{"key":"2349_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","volume":"35","author":"AK Fett","year":"2011","unstructured":"Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011;35:573\u201388.","journal-title":"Neurosci Biobehav Rev"},{"key":"2349_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neubiorev.2019.07.020","volume":"105","author":"TF Halverson","year":"2019","unstructured":"Halverson TF, Orleans-Pobee M, Merritt C, Sheeran P, Fett AK, Penn DL. Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors. Neurosci Biobehav Rev. 2019;105:212\u20139.","journal-title":"Neurosci Biobehav Rev"},{"key":"2349_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2021.100217","volume":"27","author":"S Kharawala","year":"2022","unstructured":"Kharawala S, Hastedt C, Podhorna J, Shukla H, Kappelhoff B, Harvey PD. The relationship between cognition and functioning in schizophrenia: a semi-systematic review. Schizophr Res Cogn. 2022;27:100217.","journal-title":"Schizophr Res Cogn"},{"key":"2349_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1176\/appi.ajp.2008.07081242","volume":"165","author":"KA Woodberry","year":"2008","unstructured":"Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry. 2008;165:579\u201387.","journal-title":"Am J Psychiatry"},{"key":"2349_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.schres.2011.06.017","volume":"132","author":"GM Khandaker","year":"2011","unstructured":"Khandaker GM, Barnett JH, White IR, Jones PB. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res. 2011;132:220\u20137.","journal-title":"Schizophr Res"},{"key":"2349_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2022.100246","volume":"28","author":"CR Mohn-Haugen","year":"2022","unstructured":"Mohn-Haugen CR, Mohn C, Laroi F, Teigset CM, Oie MG, Rund BR. A systematic review of premorbid cognitive functioning and its timing of onset in schizophrenia spectrum disorders. Schizophr Res Cogn. 2022;28:100246.","journal-title":"Schizophr Res Cogn"},{"key":"2349_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02718-6","volume":"14","author":"A Catalan","year":"2024","unstructured":"Catalan A, McCutcheon RA, Aymerich C, Pedruzo B, Radua J, Rodriguez V, et al. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies. Transl Psychiatry. 2024;14:15.","journal-title":"Transl Psychiatry"},{"key":"2349_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.schres.2023.01.004","volume":"252","author":"SKW Chan","year":"2023","unstructured":"Chan SKW, Liao Y, Hui CLM, Wong TY, Suen Y, Chang WC, et al. Longitudinal changes of cognitive function and its relationship with subdomains of negative symptoms in patients with adult-onset first-episode schizophrenia: a 4-year follow up study. Schizophr Res. 2023;252:181\u20138.","journal-title":"Schizophr Res"},{"key":"2349_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamapsychiatry.2022.1142","volume":"79","author":"K Jonas","year":"2022","unstructured":"Jonas K, Lian W, Callahan J, Ruggero CJ, Clouston S, Reichenberg A, et al. The course of general cognitive ability in individuals with psychotic disorders. JAMA Psychiatry. 2022;79:659\u201366.","journal-title":"JAMA Psychiatry"},{"key":"2349_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","volume":"28","author":"OD Howes","year":"2023","unstructured":"Howes OD, Onwordi EC. The synaptic hypothesis of schizophrenia version III: a master mechanism. Mol Psychiatry. 2023;28:1843\u201356.","journal-title":"Mol Psychiatry"},{"key":"2349_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000362383","volume":"36","author":"WY Li","year":"2014","unstructured":"Li WY, Chang YC, Lee LJ, Lee LJ. Prenatal infection affects the neuronal architecture and cognitive function in adult mice. Dev Neurosci. 2014;36:359\u201370.","journal-title":"Dev Neurosci"},{"key":"2349_CR22","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1523\/JNEUROSCI.1184-06.2006","volume":"26","author":"C Liston","year":"2006","unstructured":"Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, et al. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci. 2006;26:7870\u20134.","journal-title":"J Neurosci"},{"key":"2349_CR23","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164\u201378.","journal-title":"Cell"},{"key":"2349_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383.","journal-title":"Nature"},{"key":"2349_CR25","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1038\/s41380-021-01081-6","volume":"26","author":"M Druart","year":"2021","unstructured":"Druart M, Nosten-Bertrand M, Poll S, Crux S, Nebeling F, Delhaye C, et al. Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes. Mol Psychiatry. 2021;26:3489\u2013501.","journal-title":"Mol Psychiatry"},{"key":"2349_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","volume":"24","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan CW, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214\u201324.","journal-title":"Nat Neurosci"},{"key":"2349_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","volume":"17","author":"I Feinberg","year":"1982","unstructured":"Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res. 1982;17:319\u201334.","journal-title":"J Psychiatr Res"},{"key":"2349_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0022-3956(94)90009-4","volume":"28","author":"MS Keshavan","year":"1994","unstructured":"Keshavan MS, Anderson S, Pettergrew JW. Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res. 1994;28:239\u201365.","journal-title":"J Psychiatr Res"},{"key":"2349_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature12975","volume":"506","author":"SM Purcell","year":"2014","unstructured":"Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506:185\u201390.","journal-title":"Nature"},{"key":"2349_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature12929","volume":"506","author":"M Fromer","year":"2014","unstructured":"Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179\u201384.","journal-title":"Nature"},{"key":"2349_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41380-018-0041-5","volume":"24","author":"EF Osimo","year":"2019","unstructured":"Osimo EF, Beck K, Reis Marques T, Howes OD. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. Mol Psychiatry. 2019;24:549\u201361.","journal-title":"Mol Psychiatry"},{"key":"2349_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","volume":"65","author":"LJ Garey","year":"1998","unstructured":"Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2349_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"LA Glantz","year":"2000","unstructured":"Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65\u201373.","journal-title":"Arch Gen Psychiatry"},{"key":"2349_CR34","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8:348ra96.","journal-title":"Sci Transl Med"},{"key":"2349_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14122-0","volume":"11","author":"EC Onwordi","year":"2020","unstructured":"Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel M-C, Wells L, et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020;11:246.","journal-title":"Nat Commun"},{"key":"2349_CR36","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/s41380-021-01184-0","volume":"26","author":"R Radhakrishnan","year":"2021","unstructured":"Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, et al. In vivo evidence of lower synaptic vesicle density in schizophrenia. Mol Psychiatry. 2021;26:7690\u20138.","journal-title":"Mol Psychiatry"},{"key":"2349_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpsychires.2023.02.026","volume":"161","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Zhang Z, Mormino E, Davidzon G, Minzenberg MJ, Ballon J, et al. Reductions in synaptic marker SV2A in early-course Schizophrenia. J Psychiatr Res. 2023;161:213\u20137.","journal-title":"J Psychiatr Res"},{"key":"2349_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03269-8","volume":"15","author":"EC Onwordi","year":"2025","unstructured":"Onwordi EC, Whitehurst T, Shatalina E, Carr R, Mansur A, Arumuham A, et al. The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study. Transl Psychiatry. 2025;15:70.","journal-title":"Transl Psychiatry"},{"key":"2349_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jamapsychiatry.2024.3608","volume":"82","author":"MB Blasco","year":"2025","unstructured":"Blasco MB, Nisha Aji K, Ramos-Jimenez C, Leppert IR, Tardif CL, Cohen J, et al. Synaptic Density in Early Stages of Psychosis and Clinical High Risk. JAMA Psychiatry. 2025;82:171\u201380.","journal-title":"JAMA Psychiatry"},{"key":"2349_CR40","doi-asserted-by":"publisher","unstructured":"Onwordi EC, Whitehurst T, Shatalina E, Mansur A, Arumuham A, Osugo M, et al. Synaptic Terminal Density Early in the Course of Schizophrenia: an in vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A (SV2A). LID - S0006-3223(23)01353-7 [pii] LID https:\/\/doi.org\/10.1016\/j.biopsych.2023.05.022 2023(1873-2402 (Electronic)).","DOI":"10.1016\/j.biopsych.2023.05.022"},{"key":"2349_CR41","first-page":"1","volume":"2","author":"E Shatalina","year":"2024","unstructured":"Shatalina E, Onwordi EC, Whitehurst T, Whittington A, Mansur A, Arumuham A, et al. The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: a [11C]UCB-J PET and fMRI study. Imaging Neurosci (Camb). 2024;2:1\u201316.","journal-title":"Imaging Neurosci (Camb)"},{"key":"2349_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-024-01099-1","volume":"14","author":"E Shatalina","year":"2024","unstructured":"Shatalina E, Whitehurst TS, Onwordi EC, Gilbert BJ, Rizzo G, Whittington A, et al. Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [(18)F]BCPP-EF PET study. EJNMMI Res. 2024;14:41.","journal-title":"EJNMMI Res"},{"key":"2349_CR43","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Schizophrenia Spectrum and Other Psychotic Disorders. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC (2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2349_CR44","unstructured":"First MB, Williams JBW, Karg RS, Spitzer RL, Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV). (2015)."},{"key":"2349_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1176\/ajp.150.9.1349","volume":"150","author":"M Beiser","year":"1993","unstructured":"Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry. 1993;150:1349\u201354.","journal-title":"Am J Psychiatry"},{"key":"2349_CR46","first-page":"915","volume":"31","author":"E Bulzacka","year":"2016","unstructured":"Bulzacka E, Meyers JE, Boyer L, Le Gloahec T, Fond G, Szoke A, et al. WAIS-IV seven-subtest short form: validity and clinical use in schizophrenia. Arch Clin Neuropsychol. 2016;31:915\u201325.","journal-title":"Arch Clin Neuropsychol"},{"key":"2349_CR47","doi-asserted-by":"crossref","unstructured":"Wechsler D. WAIS-III: Administration and Scoring Manual: Wechsler Adult Intelligence Scale, Psychological Corporation, San Antonio, TX (1997).","DOI":"10.1037\/t49755-000"},{"key":"2349_CR48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1017\/S1355617702860131","volume":"8","author":"P Bright","year":"2002","unstructured":"Bright P, Jaldow E, Kopelman MD. The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc. 2002;8:847\u201354.","journal-title":"J Int Neuropsychol Soc"},{"key":"2349_CR49","doi-asserted-by":"crossref","unstructured":"Mansur A, Rabiner EA, Comley RA, et al. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J. J Nucl Med. 2020;61:96\u2013103.","DOI":"10.2967\/jnumed.119.228080"},{"key":"2349_CR50","doi-asserted-by":"crossref","unstructured":"Grabner G, Janke AL, Budge MM, Smith D, Pruessner J, Collins DL, editors. Symmetric Atlasing and Model Based Segmentation: An Application to the Hippocampus in Older Adults. Medical Image Computing and Computer-Assisted Intervention \u2013 MICCAI 2006; Berlin, Heidelberg: Springer Berlin Heidelberg.","DOI":"10.1007\/11866763_8"},{"key":"2349_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M, et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage. 2011;54:264\u201377.","journal-title":"Neuroimage"},{"key":"2349_CR52","doi-asserted-by":"crossref","unstructured":"Dubois J, Galdi P, Paul LK, Adolphs R. A distributed brain network predicts general intelligence from resting-state human neuroimaging data. Philos Trans R Soc Lond B Biol Sci. 2018;373:20170284.","DOI":"10.1098\/rstb.2017.0284"},{"key":"2349_CR53","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/hbm.26164","volume":"44","author":"ED Anderson","year":"2023","unstructured":"Anderson ED, Barbey AK. Investigating cognitive neuroscience theories of human intelligence: a connectome-based predictive modeling approach. Hum Brain Mapp. 2023;44:1647\u201365.","journal-title":"Hum Brain Mapp"},{"key":"2349_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78157-0","volume":"14","author":"MA Hussain","year":"2024","unstructured":"Hussain MA, LaMay D, Grant E, Ou Y. Deep learning of structural MRI predicts fluid, crystallized, and general intelligence. Sci Rep. 2024;14:27935.","journal-title":"Sci Rep"},{"key":"2349_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15:273\u201389.","journal-title":"NeuroImage"},{"key":"2349_CR56","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/0271678X17724947","volume":"38","author":"SJ Finnema","year":"2018","unstructured":"Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, et al. Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. J Cereb Blood Flow Metab. 2018;38:2041\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2349_CR57","doi-asserted-by":"crossref","unstructured":"Rossano S, Toyonaga T, Finnema SJ, Naganawa M, Lu Y, Nabulsi N, et al. Assessment of a white matter reference region for (11)C-UCB-J PET quantification. J Cereb Blood Flow Metab. 2019:271678X19879230.","DOI":"10.1177\/0271678X19879230"},{"key":"2349_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2016","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am J Psychiatry. 2016;173:44\u201352.","journal-title":"Am J Psychiatry"},{"key":"2349_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B (Methodol)"},{"key":"2349_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01515-3","volume":"11","author":"EC Onwordi","year":"2021","unstructured":"Onwordi EC, Whitehurst T, Mansur A, Statton B, Berry A, Quinlan M, et al. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. Transl Psychiatry. 2021;11:393.","journal-title":"Transl Psychiatry"},{"key":"2349_CR61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1037\/a0014708","volume":"23","author":"RI Mesholam-Gately","year":"2009","unstructured":"Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009;23:315\u201336.","journal-title":"Neuropsychology"},{"key":"2349_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00259-023-06487-8","volume":"51","author":"T Toyonaga","year":"2024","unstructured":"Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, et al. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [(11)C]UCB-J. Eur J Nucl Med Mol Imaging. 2024;51:1012\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2349_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1124254","volume":"17","author":"XT Fang","year":"2023","unstructured":"Fang XT, Volpi T, Holmes SE, Esterlis I, Carson RE, Worhunsky PD. Linking resting-state network fluctuations with systems of coherent synaptic density: A multimodal fMRI and (11)C-UCB-J PET study. Front Hum Neurosci. 2023;17:1124254.","journal-title":"Front Hum Neurosci"},{"key":"2349_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.117877","volume":"232","author":"L Michiels","year":"2021","unstructured":"Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, et al. Synaptic density in healthy human aging is not influenced by age or sex: a (11)C-UCB-J PET study. Neuroimage. 2021;232:117877.","journal-title":"Neuroimage"},{"key":"2349_CR65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nucmedbio.2022.06.007","volume":"112-113","author":"KB Andersen","year":"2022","unstructured":"Andersen KB, Hansen AK, Knudsen K, Schacht AC, Damholdt MF, Brooks DJ, et al. Healthy brain aging assessed with [(18)F]FDG and [(11)C]UCB-J PET. Nucl Med Biol. 2022;112-113:52\u20138.","journal-title":"Nucl Med Biol"},{"key":"2349_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neubiorev.2021.03.028","volume":"126","author":"DP Baldez","year":"2021","unstructured":"Baldez DP, Biazus TB, Rabelo-da-Ponte FD, Nogaro GP, Martins DS, Kunz M, et al. The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: Network meta-analyses of randomized controlled trials. Neurosci Biobehav Rev. 2021;126:265\u201375.","journal-title":"Neurosci Biobehav Rev"},{"key":"2349_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jamapsychiatry.2024.2890","volume":"82","author":"L Feber","year":"2025","unstructured":"Feber L, Peter NL, Chiocchia V, Schneider-Thoma J, Siafis S, Bighelli I, et al. Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta-Analysis. JAMA Psychiatry. 2025;82:47\u201356.","journal-title":"JAMA Psychiatry"},{"key":"2349_CR68","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2023.04.004","volume":"94","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Harrison PJ, Howes OD, McGuire PK, Taylor DM, Pillinger T. Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System. Biol Psychiatry. 2023;94:561\u20138.","journal-title":"Biol Psychiatry"},{"key":"2349_CR69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/npr2.12423","volume":"44","author":"R Yamazaki","year":"2024","unstructured":"Yamazaki R, Matsumoto J, Ito S, Nemoto K, Fukunaga M, Hashimoto N, et al. Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function. Neuropsychopharmacol Rep. 2024;44:206\u201315.","journal-title":"Neuropsychopharmacol Rep"},{"key":"2349_CR70","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1017\/S0033291721004815","volume":"53","author":"AJ Watson","year":"2023","unstructured":"Watson AJ, Giordano A, Suckling J, Barnes TRE, Husain N, Jones PB, et al. Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers. Psychol Med. 2023;53:2842\u201351.","journal-title":"Psychol Med"},{"key":"2349_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.3725","volume":"49","author":"CR Marshall","year":"2017","unstructured":"Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27\u201335.","journal-title":"Nat Genet"},{"key":"2349_CR72","doi-asserted-by":"crossref","unstructured":"Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, et al. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophr Bull. 2020;46:374\u201386.","DOI":"10.1093\/schbul\/sbz060"},{"key":"2349_CR73","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.tics.2017.06.006","volume":"21","author":"JK Forsyth","year":"2017","unstructured":"Forsyth JK, Lewis DA. Mapping the consequences of impaired synaptic plasticity in schizophrenia through development: an integrative model for diverse clinical features. Trends Cogn Sci. 2017;21:760\u201378.","journal-title":"Trends Cogn Sci"},{"key":"2349_CR74","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","volume":"74","author":"SP Brugger","year":"2017","unstructured":"Brugger SP, Howes OD. Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis. JAMA Psychiatry. 2017;74:1104\u201311.","journal-title":"JAMA Psychiatry"},{"key":"2349_CR75","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/schbul\/sby094","volume":"45","author":"A O\u2019Neill","year":"2019","unstructured":"O\u2019Neill A, Mechelli A, Bhattacharyya S. Dysconnectivity of large-scale functional networks in early psychosis: a meta-analysis. Schizophr Bull. 2019;45:579\u201390.","journal-title":"Schizophr Bull"},{"key":"2349_CR76","first-page":"355","volume":"43","author":"LS Czepielewski","year":"2017","unstructured":"Czepielewski LS, Wang L, Gama CS, Barch DM. The relationship of intellectual functioning and cognitive performance to brain structure in schizophrenia. Schizophr Bull. 2017;43:355\u201364.","journal-title":"Schizophr Bull"},{"key":"2349_CR77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.schres.2018.06.048","volume":"202","author":"A Caldiroli","year":"2018","unstructured":"Caldiroli A, Buoli M, van Haren NEM, de Nijs J, Altamura AC, Cahn W. The relationship of IQ and emotional processing with insula volume in schizophrenia. Schizophr Res. 2018;202:141\u20138.","journal-title":"Schizophr Res"},{"key":"2349_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41537-024-00434-8","volume":"10","author":"N Kang","year":"2024","unstructured":"Kang N, Chung S, Lee SH, Bang M. Cerebro-cerebellar gray matter abnormalities associated with cognitive impairment in patients with recent-onset and chronic schizophrenia. Schizophrenia (Heidelb). 2024;10:11.","journal-title":"Schizophrenia (Heidelb)"},{"key":"2349_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pscychresns.2017.04.007","volume":"264","author":"K Dempster","year":"2017","unstructured":"Dempster K, Norman R, Theberge J, Densmore M, Schaefer B, Williamson P. Cognitive performance is associated with gray matter decline in first-episode psychosis. Psychiatry Res Neuroimaging. 2017;264:46\u201351.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2349_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.nicl.2017.01.034","volume":"14","author":"JA Bernard","year":"2017","unstructured":"Bernard JA, Russell CE, Newberry RE, Goen JR, Mittal VA. Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis. Neuroimage Clin. 2017;14:450\u201363.","journal-title":"Neuroimage Clin"},{"key":"2349_CR81","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/hbm.24365","volume":"40","author":"S Kohler","year":"2019","unstructured":"Kohler S, Wagner G, Bar KJ. Activation of brainstem and midbrain nuclei during cognitive control in medicated patients with schizophrenia. Hum Brain Mapp. 2019;40:202\u201313.","journal-title":"Hum Brain Mapp"},{"key":"2349_CR82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41386-024-01943-x","volume":"50","author":"O Howes","year":"2024","unstructured":"Howes O, Marcinkowska J, Turkheimer FE, Carr R. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging. Neuropsychopharmacology. 2024;50:164\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"2349_CR83","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1176\/appi.ajp.2016.16050610","volume":"174","author":"VL Cropley","year":"2017","unstructured":"Cropley VL, Klauser P, Lenroot RK, Bruggemann J, Sundram S, Bousman C, et al. Accelerated gray and white matter deterioration with age in schizophrenia. Am J Psychiatry. 2017;174:286\u201395.","journal-title":"Am J Psychiatry"},{"key":"2349_CR84","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.biopsych.2015.02.008","volume":"78","author":"A Vita","year":"2015","unstructured":"Vita A, De Peri L, Deste G, Barlati S, Sacchetti E. The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? a meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biol Psychiatry. 2015;78:403\u201312.","journal-title":"Biol Psychiatry"},{"key":"2349_CR85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pneurobio.2011.08.003","volume":"95","author":"MR Bennett","year":"2011","unstructured":"Bennett MR. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog Neurobiol. 2011;95:275\u2013300.","journal-title":"Prog Neurobiol"},{"key":"2349_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41386-022-01426-x","volume":"48","author":"OD Howes","year":"2023","unstructured":"Howes OD, Cummings C, Chapman GE, Shatalina E. Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes. Neuropsychopharmacology. 2023;48:151\u201367.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02349-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:12:58Z","timestamp":1777367578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02349-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02349-7","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EAR and RNG are employees of Invicro LLC. AM was an employee of Invicro LLC during the completion of much of this work. TRM is an employee and has shares of Pasithea Therapeutics, and has received honoraria for speaking and chairing from Lundbeck, Janssen, and Astellas and received honoraria to participate in advisory boards organized by Angelini Pharmaceuticals. In the last 3 years, SJ has given nonpromotional educational talks for Lundbeck, Janssen, and Sunovion. ODH has received investigator-initiated research funding from and\/or participated in advisory\/speaker meetings organized by Angellini, Autifony, Biogen, Boehringer Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche, and Viatris\/Mylan. ODH has a patent for the use of dopaminergic imaging. The other authors report no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}